HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andy Chen Selected Research

A 77636

1/2017Inhibitory Effects of Dopamine Receptor D1 Agonist on Mammary Tumor and Bone Metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andy Chen Research Topics

Disease

10Neoplasms (Cancer)
01/2020 - 06/2004
5Breast Neoplasms (Breast Cancer)
01/2020 - 01/2017
5Neoplasm Metastasis (Metastasis)
12/2019 - 01/2014
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2021 - 01/2016
2Infections
01/2022 - 11/2020
2Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2022 - 03/2017
2Wounds and Injuries (Trauma)
01/2022 - 12/2018
2Bone Resorption
02/2018 - 01/2018
2Hodgkin Disease (Hodgkin's Disease)
12/2016 - 01/2016
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
03/2022
1Surgical Wound Infection
01/2022
1Lymphoma (Lymphomas)
07/2021
1Hematologic Neoplasms (Hematological Malignancy)
01/2021
1Thrombosis (Thrombus)
11/2020
1Job Syndrome (Hyper-IgE Syndrome)
01/2020
1Bone Diseases (Bone Disease)
01/2020
1Insulin Resistance
09/2018
1Disease Susceptibility (Diathesis)
09/2018
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2018
1Bone Fractures (Bone Fracture)
01/2018
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2017
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2016
1Arthritis (Polyarthritis)
04/2015
1Inflammation (Inflammations)
04/2015
1Virus Diseases (Viral Diseases)
01/2015
1Cardiovascular Diseases (Cardiovascular Disease)
10/2014
1Uveal melanoma
01/2014
1Melanoma (Melanoma, Malignant)
01/2014
1Disease Progression
01/2014
1Osteoporosis
07/2013
1Chondrosarcoma
09/2012
1Food Hypersensitivity (Food Allergy)
01/2006
1Pancreatic Neoplasms (Pancreatic Cancer)
06/2004

Drug/Important Bio-Agent (IBA)

3Conditioned Culture MediaIBA
01/2020 - 01/2018
3salubrinalIBA
04/2015 - 09/2012
2Chimeric Antigen ReceptorsIBA
01/2022 - 01/2021
2Volatile Organic CompoundsIBA
01/2020 - 12/2019
2Transcription Factors (Transcription Factor)IBA
12/2019 - 01/2018
2RNA (Ribonucleic Acid)IBA
12/2018 - 01/2018
2NFATC Transcription FactorsIBA
09/2018 - 01/2018
2Phosphotransferases (Kinase)IBA
09/2018 - 06/2004
2PD 407824IBA
09/2018 - 01/2018
2DNA (Deoxyribonucleic Acid)IBA
02/2018 - 01/2017
2Dopamine Receptors (Dopamine Receptor)IBA
01/2018 - 01/2017
2Proteins (Proteins, Gene)FDA Link
01/2018 - 06/2004
2CollagenIBA
01/2018 - 04/2015
2Brentuximab VedotinIBA
12/2016 - 01/2016
1ibrutinibIBA
03/2022
1obinutuzumabIBA
03/2022
1Anti-Bacterial Agents (Antibiotics)IBA
01/2022
1Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
07/2021
1poly(bis(octafluoropentoxy)phosphazene)IBA
11/2020
1Biocompatible Materials (Biomaterials)IBA
11/2020
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2020
1OsteopontinIBA
01/2020
1Mevalonic Acid (Mevalonate)IBA
12/2019
1CholesterolIBA
12/2019
1Pharmaceutical PreparationsIBA
12/2019
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
12/2019
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
12/2019
1pitavastatin (itavastatin)FDA Link
12/2019
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2019
1Bone Morphogenetic Protein 2IBA
12/2019
1VinculinIBA
01/2019
1DioxinsIBA
09/2018
13- (carbamoylamino)- 5- (3- fluorophenyl)- N- (3- piperidyl)thiophene- 2- carboxamideIBA
09/2018
1Endocrine DisruptorsIBA
09/2018
1Checkpoint Kinase 1IBA
02/2018
1Trifluoperazine (Stelazine)FDA LinkGeneric
01/2018
1Collagen Type I (Type I Collagen)IBA
01/2018
1ElementsIBA
01/2018
1Sepharose (Agarose)IBA
01/2018
1Fluphenazine (Prolixin)FDA LinkGeneric
01/2018
1Dopamine (Intropin)FDA LinkGeneric
01/2018
1BiglycanIBA
01/2018
1Immunoconjugates (Immunoconjugate)IBA
03/2017
1pinatuzumab vedotinIBA
03/2017
1Rituximab (Mabthera)FDA Link
03/2017
1S100 Calcium-Binding Protein A4IBA
01/2017
1A 77636IBA
01/2017
1Messenger RNA (mRNA)IBA
01/2017
1CytokinesIBA
04/2015
1Prokaryotic Initiation Factor-2IBA
01/2015
1CalciumIBA
10/2014
1RANK LigandIBA
07/2013
1Peptide Initiation Factors (Initiation Factor)IBA
09/2012
1Immunoglobulin E (IgE)IBA
01/2006
1Epidermal Growth Factor (EGF)IBA
06/2004
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
06/2004
1ErbB Receptors (EGF Receptor)IBA
06/2004

Therapy/Procedure

2Radiotherapy
01/2014 - 09/2012
1Antibiotic Prophylaxis
01/2022
1Therapeutics
01/2022
1Pancreaticoduodenectomy
01/2022
1Drug Therapy (Chemotherapy)
09/2018
1Homologous Transplantation
01/2018
1Autologous Transplantation
01/2018
1Cell Transplantation
01/2016
1Brachytherapy
01/2014
1Lasers (Laser)
06/2004